We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Stryker's (SYK) Gamma4 Expansion Set to Boost Fracture Healing
Read MoreHide Full Article
Stryker Corporation (SYK - Free Report) recently expanded its Gamma4 Hip Fracture Nailing System by adding an intermediate nail called the RC Lag Screw along with an anti-rotation clip with sleeve components.
The phase two launch of these additional Gamma4 features is set to provide additional support to surgeons for the treatment of complex hip fractures.
Price Performance
For the past six months, SYK’s shares have rallied 5.7% against the industry’s decline of 0.6%. The S&P 500 increased 4.7% in the same time frame.
Image Source: Zacks Investment Research
More on the News
Launched in 2022, the Gamma4 System is used for the treatment of both stable and unstable fractures, bone deformity correction, and bone stabilization in the intracapsular, trochanteric, subtrochanteric, and shaft regions of the femur (including osteoporotic and osteopenic bone).
In June 2023, the 510(k) clearance was granted for the latest line expansion, which includes the Gamma4 intermediate nail and RC Lag Screw.
When compared to the normal Gamma4 lag screw, the Gamma4 RC Lag Screw offers a 15% increase in cutout resistance while the blades provide 2 mm more surface area contact inside the femoral head.
In rotationally unstable femoral head neck fragments, the anti-rotation clip and sleeve components offer intraoperative stability. Using an anti-rotation clip and sleeve during lag screw insertion, hip fractures involving the basicervical neck region can be temporarily stabilized.
The intermediate nail aimed distally can now be used to treat intertrochanteric hip fractures with subtrochanteric extension.
Industry Prospects
Per a report by Coherent Market Insights, the global Intramedullary Nail Market size is expected to reach $1.3 billion by 2030 from $794.8 million in 2023, at a growth rate of 7.6%.
Intramedullary nails are metal rods that are inserted into the medullary canal of long bones to stabilize fractures. The market is driven by the rising incidence of musculoskeletal conditions that require fixation surgeries.
Notable Developments
According to a recent announcement from SYK, Blueprint Mixed Reality Guidance has been used in the first shoulder arthroplasty procedures.
By planning and performing the treatment using precise images of the patient's shoulder, doctors can reduce the likelihood of an implant being placed erroneously with this technology.
Some other top-ranked stocks to consider in the broader medical space are Integer Holdings Corporation (ITGR - Free Report) , Acadia Healthcare (ACHC - Free Report) , and Universal Health Services (UHS - Free Report) .
Integer Holdings, presently carrying a Zacks Rank of 2, has an estimated long-term growth rate of 15.8%. ITGR’s earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 11.9%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Integer Holdings’ shares have rallied 43.5% in the past year against the industry’s 3.7% decline.
Acadia Healthcare, carrying a Zacks Rank of 2 at present, has an estimated long-term growth rate of 10.4%. ACHC’s long-term earnings are expected to grow at 11.2%.
Acadia’s shares have gained 11.7% in the past six months against the industry’s decline of 5%.
Universal Health Services, carrying a Zacks Rank of 2 at present, has an estimated growth rate of 4.4% for 2024. UHS’s earnings surpassed estimates in all the trailing four quarters, delivering an average surprise of 5.47%.
UHS’s shares have gained 1.9% in the past six months against the industry’s 5% decline.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Stryker's (SYK) Gamma4 Expansion Set to Boost Fracture Healing
Stryker Corporation (SYK - Free Report) recently expanded its Gamma4 Hip Fracture Nailing System by adding an intermediate nail called the RC Lag Screw along with an anti-rotation clip with sleeve components.
The phase two launch of these additional Gamma4 features is set to provide additional support to surgeons for the treatment of complex hip fractures.
Price Performance
For the past six months, SYK’s shares have rallied 5.7% against the industry’s decline of 0.6%. The S&P 500 increased 4.7% in the same time frame.
Image Source: Zacks Investment Research
More on the News
Launched in 2022, the Gamma4 System is used for the treatment of both stable and unstable fractures, bone deformity correction, and bone stabilization in the intracapsular, trochanteric, subtrochanteric, and shaft regions of the femur (including osteoporotic and osteopenic bone).
In June 2023, the 510(k) clearance was granted for the latest line expansion, which includes the Gamma4 intermediate nail and RC Lag Screw.
When compared to the normal Gamma4 lag screw, the Gamma4 RC Lag Screw offers a 15% increase in cutout resistance while the blades provide 2 mm more surface area contact inside the femoral head.
In rotationally unstable femoral head neck fragments, the anti-rotation clip and sleeve components offer intraoperative stability. Using an anti-rotation clip and sleeve during lag screw insertion, hip fractures involving the basicervical neck region can be temporarily stabilized.
The intermediate nail aimed distally can now be used to treat intertrochanteric hip fractures with subtrochanteric extension.
Industry Prospects
Per a report by Coherent Market Insights, the global Intramedullary Nail Market size is expected to reach $1.3 billion by 2030 from $794.8 million in 2023, at a growth rate of 7.6%.
Intramedullary nails are metal rods that are inserted into the medullary canal of long bones to stabilize fractures. The market is driven by the rising incidence of musculoskeletal conditions that require fixation surgeries.
Notable Developments
According to a recent announcement from SYK, Blueprint Mixed Reality Guidance has been used in the first shoulder arthroplasty procedures.
By planning and performing the treatment using precise images of the patient's shoulder, doctors can reduce the likelihood of an implant being placed erroneously with this technology.
Stryker Corporation Price
Stryker Corporation price | Stryker Corporation Quote
Zacks Rank & Other Stocks to Consider
SYK carries a Zacks Rank #2 (Buy) at present.
Some other top-ranked stocks to consider in the broader medical space are Integer Holdings Corporation (ITGR - Free Report) , Acadia Healthcare (ACHC - Free Report) , and Universal Health Services (UHS - Free Report) .
Integer Holdings, presently carrying a Zacks Rank of 2, has an estimated long-term growth rate of 15.8%. ITGR’s earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 11.9%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Integer Holdings’ shares have rallied 43.5% in the past year against the industry’s 3.7% decline.
Acadia Healthcare, carrying a Zacks Rank of 2 at present, has an estimated long-term growth rate of 10.4%. ACHC’s long-term earnings are expected to grow at 11.2%.
Acadia’s shares have gained 11.7% in the past six months against the industry’s decline of 5%.
Universal Health Services, carrying a Zacks Rank of 2 at present, has an estimated growth rate of 4.4% for 2024. UHS’s earnings surpassed estimates in all the trailing four quarters, delivering an average surprise of 5.47%.
UHS’s shares have gained 1.9% in the past six months against the industry’s 5% decline.